Pot sector falls into correction territory, but MedMen jumps after $682 million acquisition

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 1 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 4%
  • Publisher: 97%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

A key tracker of the marijuana industry has fallen into correction territory -- but there's still one pot stock that's a bright spot today.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки

Igc

CRON up 8% and ACBFF up 5%. You ain’t smoking weed🌬😳

Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 3. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Marijuana stocks to watch: MedMen turns a vision into reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality. Ticker isn’t on robinhood?
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Marijuana stocks to watch: MedMen’s vision becomes reality with largest-ever U.S. pot mergerMedMen Enterprises co-founder Adam Bierman believes the company’s $682 million acquisition of PharmCann last week marks the culmination of the U.S. cannabis industry’s transformation from vision to reality.
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »

'Retail is the place to be' in cannabis, says MedMen CEO after 'blockbuster' PharmaCann acquisitionJim Cramer sits down with MedMen co-founder and CEO Adam Bierman, whose cannabis retailer will absorb PharmaCann in the largest marijuana-related acquisition in U.S. history.
Источник: CNBC - 🏆 12. / 72 Прочитайте больше »

The CEO of the biggest cannabis company in the US reveals his strategy for defending against multi-billion private equity fundsBI PRIME: Hot off of a $682 million acquisition, Adam Bierman, the CEO of MedMen — now the biggest cannabis company in the US — opens up about who his biggest competition is and how he's defending against them.
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

A competitor is emerging to challenge the marijuana retail chain dominating the industry, and it just closed a $640 million acquisitionBI PRIME: iAnthus, a multistate cannabis dispensary operator, acquired Toronto-based MPX Bioceutical in a $640 million all-stock transaction. The deal comes on the heels of rival MedMen's $682 million acquisition of PharmaCann. BIPrime Are they considering a 'joint' venture?
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »

Cannabis industry shops for a suit and tieMoney is pouring into weed as valuations rise and legal barriers fall – nudged further by recent U.S. election results. Companies like Canopy, Aurora and MedMen are starting to take on a veneer of acceptability. That doesn’t make them good investments, but it’s progress.
Источник: Breakingviews - 🏆 470. / 51 Прочитайте больше »

High-end marijuana retailer MedMen just spent $682 million on the largest US cannabis acquisition in historyMedMen, one of the booming cannabis industry's most recognizable brands, acquired medical marijuana retailer PharmaCann in a $682 million stock transaction. It's the largest cannabis acquisition in the US to date. ShopMedMen Oh Hell Yea..... I own some stock LetsDoThis
Источник: BusinessInsider - 🏆 729. / 51 Прочитайте больше »